RA Capital Management’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,021,764
Closed -$2.86M 98
2022
Q1
$2.86M Sell
1,021,764
-233,553
-19% -$654K 0.06% 92
2021
Q4
$5.65M Hold
1,255,317
0.1% 93
2021
Q3
$10.5M Buy
+1,255,317
New +$10.5M 0.15% 73